Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 5.12
+0.01 (0.20%)
Apr 17, 2026, 11:22 AM HKT
Jiangsu Recbio Technology Employees
Jiangsu Recbio Technology had 491 employees as of December 31, 2025. The number of employees decreased by 40 or -7.53% compared to the previous year.
Employees
491
Change
-40
Growth
-7.53%
Revenue / Employee
28.84K HKD
Profits / Employee
-1.38M HKD
Market Cap
3.15B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 491 | -40 | -7.53% |
| Jun 30, 2025 | 507 | - | - |
| Dec 31, 2024 | 531 | 59 | 12.50% |
| Dec 31, 2023 | 472 | -60 | -11.28% |
| Dec 31, 2022 | 532 | 111 | 26.37% |
| Dec 31, 2021 | 421 | -10 | -2.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Viva Biotech Holdings | 2,169 |
| AIM Vaccine | 1,466 |
| BioDlink International Company | 613 |
| Mirxes Holding Company | 347 |
| Clover Biopharmaceuticals | 243 |
| Beijing Luzhu Biotechnology | 205 |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 202 |
| TYK Medicines | 173 |